UPDATE: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics' Precice Devices - Letter to Health Care Providers Today, the U.S. Food and Drug Administration (FDA) issued an updated Letter to Health Care Providers to provide updated information on titanium-based Precice devices, including updated labeling. Stainless steel-based Precice devices remain recalled from the U.S. market. The Letter to Health Care Providers includes: - Updated recommendations for titanium-based Precice devices (Precice IMLL Precice Short, Precice Freedom, and Precice Unyte).
- Actions the FDA continues to take to evaluate potential concerns with all Precice devices.
- Instructions for reporting problems with all Precice devices to the FDA.
Questions? If you have questions about Precice devices, contact the Division of Industry and Consumer Education (DICE). |
No comments:
Post a Comment